from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2015c/-

LFCtreatmentdescriptionclass of inhibitor

-0.489

Amikacinug/mL Amikacintranslation

-0.546

Cap5-10ug/mL Capreomycintranslation

-0.555

Rox10-50 ug/mL Roxithromycintranslation

-0.327

SM2-5 ug/mL Streptomycintranslation

0.026

Tet5-10 ug/mL Tetracyclinetranslation

0.330

Rif0.2-5ug/mL Rifampicintranscription

-0.393

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.545

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.960

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.296

CPZ10-50 ug/mL Chlorpromazinerespiration

0.009

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.567

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.657

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.360

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.251

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.401

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.452

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.556

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.972

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.614

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

2.182

KCN5-20 ug/mL Potassium cyaniderespiration

-0.495

NaN30.2-2 mM Sodium aziderespiration

0.145

Nigericin50 uM Nigericinrespiration

0.638

TRC10-150 ug/mL Triclosanrespiration

0.126

TRZ10-25 ug/mL Thioridazinerespiration

0.534

Valinomycin0.5-10 uM Valinomycinrespiration

-0.589

ZnSO42 mM ZnSO4respiration

1.167

menadione6-10 ug/mL Menadionerespiration

-0.290

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.398

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.536

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.951

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.895

NRP_1Non-replicating persistence stage 1dosRassociated

-0.588

Amp0.2mg/mL AmpicillincellWall

-0.531

Cephalexin20-100 ug/mL CephalexincellWall

-0.467

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.380

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.256

EMB10-20 ug/mL EthambutolcellWall

-0.532

Eta12-40 ug/mL EthionamidecellWall

-0.640

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.393

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-1.204

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.133

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.184

BZA0.12 mg/mL BenzamidearomaticAmides

0.095

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.223

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

1.570

H2O24 mM hydrogen peroxideDNAdamaging

1.742

Levo10 ug/mL LevofloxacinDNAdamaging

0.053

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.614

Novobiocin10 ug/mL NovobiocinDNAdamaging

3.633

Oflox5-10 ug/mL OfloxacinDNAdamaging

1.267

UVUV-irradiationDNAdamaging

-0.054

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.549

Antimycin12.5-50 ug/mL Antimycin A?

-0.459

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.016

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.216

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.374

PA8240.2-2 ug/mL PA-824?

0.362

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.044

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.470

Verapamil50 uM Verapamil?

-0.650

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.858

methoxatin10-20 ug/mL Methoxatin?